Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N McAtee

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, R F Murphy, et al.
Annals of Internal Medicine|April 1, 1988
Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot studyA Surbone, R Yarchoan, N McAtee, et al.
Blood|August 1, 1990
Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infectionJ M Pluda, R Yarchoan, P D Smith, et al.
Cancer Research|October 15, 1993
A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, S M Steinberg, et al.
American Journal of Ophthalmology|August 15, 1988
Suramin keratopathyE J Holland, C A Stein, A G Palestine, et al.
Lancet (London, England)|January 16, 1988
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)R Yarchoan, C F Perno, R V Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinomaJ L Grem, N McAtee, R F Murphy, et al.
The Cancer Journal From Scientific American|May 1, 1995
Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinomaH R Alexander, J L Grem, J M Hamilton, et al.
Annals of Surgical Oncology|April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancerD N Danforth, J Zujewski, J O'Shaughnessy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumorsJ L Grem, J M Sorensen, E Cullen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, R F Murphy, et al.
Annals of Internal Medicine|April 1, 1988
Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot studyA Surbone, R Yarchoan, N McAtee, et al.
Blood|August 1, 1990
Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infectionJ M Pluda, R Yarchoan, P D Smith, et al.
Cancer Research|October 15, 1993
A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, S M Steinberg, et al.
American Journal of Ophthalmology|August 15, 1988
Suramin keratopathyE J Holland, C A Stein, A G Palestine, et al.
Lancet (London, England)|January 16, 1988
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)R Yarchoan, C F Perno, R V Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinomaJ L Grem, N McAtee, R F Murphy, et al.
The Cancer Journal From Scientific American|May 1, 1995
Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinomaH R Alexander, J L Grem, J M Hamilton, et al.
Annals of Surgical Oncology|April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancerD N Danforth, J Zujewski, J O'Shaughnessy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumorsJ L Grem, J M Sorensen, E Cullen, et al.
Pageof 3